Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

DICERNA PHARMACEUTICALS, INC.

(DRNA)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über DICERNA PHARMACEUTICALS, INC.
22:02DICERNA PHARMACEUTICALS : Announces Data to Be Presented at American Society of Nephrology..
14.10.DICERNA PHARMACEUTICALS : to Present Phase 1 Data for Two Drug Candidates at Liver Disease..
14.10.DICERNA PHARMACEUTICALS : Announces Poster Presentations at American Association for the S..
12.10.DICERNA PHARMACEUTICALS : Corporate Overview
01.10.DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29.09.DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
28.09.DICERNA PHARMACEUTICALS : Begins Early-Stage Trial of Potential Treatment for Alcoholic Us..
28.09.DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
28.09.Dicerna Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of DCR-AUD
22.09.DICERNA PHARMACEUTICALS : Names Rob Ciappenelli Chief Strategy Officer
22.09.DICERNA PHARMACEUTICALS : Announces New Executive Leadership Appointments
22.09.Dicerna Pharmaceuticals, Inc. Announces Executive Appointments
21.09.INSIDER SELL : Dicerna Pharmaceuticals
08.09.DICERNA PHARMACEUTICALS : Corporate Overview
02.09.DICERNA PHARMACEUTICALS : to Participate in 16th Annual Citi Biopharma Conference
12.08.DICERNA PHARMACEUTICALS : Corporate Overview
12.08.NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
11.08.INSIDER TRENDS : Insider Buying Continued with Purchase of Dicerna Pharmaceuticals Stock
09.08.UPDATE : Dicerna Pharma Logs Wider Q2 Loss, Revenue Up Slightly; Shares Fall
09.08.DICERNA PHARMACEUTICALS : Logs Wider Q2 Loss, Revenue Up Slightly
09.08.DICERNA PHARMACEUTICALS : Q2 Earnings Snapshot
09.08.DICERNA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
09.08.Dicerna Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Jun..
09.08.DICERNA PHARMACEUTICALS INC : Results of Operations and Financial Condition (form 8-K)
09.08.DICERNA PHARMACEUTICALS : Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Reports Q2 Revenue..
09.08.DICERNA PHARMACEUTICALS : Announces Second Quarter 2021 Financial Results and Provides a B..
06.08.Top Midday Decliners
06.08.Wall Street Sees Narrowly Mixed Open, Strong Jobs Data in Focus
06.08.DICERNA PHARMACEUTICALS INC : Regulation FD Disclosure (form 8-K)
06.08.Top Premarket Decliners
06.08.DICERNA PHARMACEUTICALS : Declines Pre-Bell Friday After Primary Hyperoxaluria Subtype 2 P..
05.08.DICERNA PHARMACEUTICALS : Reports Positive Top-Line Results From PHYOX™2 Pivotal Cli..
05.08.Dicerna Pharmaceuticals, Inc. Reports Positive Top-Line Results From PHYOX™2 Pivotal Cl..
02.08.DICERNA PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
30.07.DICERNA PHARMACEUTICALS : Announces FDA Clearance of Investigational New Drug Application ..
29.07.DICERNA PHARMACEUTICALS' : New Drug Application Targeting Alcohol Use Disorder Gets FDA Cl..
29.07.DICERNA PHARMACEUTICALS : Announces FDA Clearance of Investigational New Drug (IND) Applic..
29.07.Dicerna Pharmaceuticals, Inc. Announces FDA Clearance of Investigational New Drug Appli..
29.07.Dicerna Announces FDA Clearance of Investigational New Drug Application for DCR-AUD for..
23.07.DICERNA PHARMACEUTICALS : Corporate Overview
21.07.SECTOR UPDATE : Health Care Stocks Mixed Ahead of Wednesday Close
21.07.SECTOR UPDATE : Health Care Stocks Mixed, Nearly Flat Wednesday
21.07.DICERNA PHARMACEUTICALS : Reports Positive Interim Data From Phase 1 Study of Belcesiran i..
21.07.DICERNA PHARMACEUTICALS : Announces Interim Results From Phase 1 Trial of Belcesiran for T..
21.07.Dicerna Pharmaceuticals, Inc Announces Interim Results From Phase 1 Trial of Belcesiran..
08.07.DICERNA PHARMACEUTICALS : Corporate Overview
02.07.DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
01.07.DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22.06.DICERNA PHARMACEUTICALS : Starts Patient Dosing in Phase 2 Trial for Rare Liver Disease Dr..
22.06.DICERNA PHARMACEUTICALS : Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of B..
22.06.Dicerna Pharmaceuticals, Inc. Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Tri..
18.06.INSIDER TRENDS : Dicerna Pharmaceuticals Insider Converts/Exercises Derivative Security, S..
17.06.DICERNA PHARMACEUTICALS : Announces Dosing Completion in Nedosiran PHYOX4 Clinical Trial f..
16.06.DICERNA PHARMACEUTICALS : Completes Dosing in Study of Nedosiran to Treat Primary Hyperoxa..
16.06.DICERNA PHARMACEUTICALS : Announces Dosing Completion in Nedosiran PHYOX™4 Clinical ..
16.06.Dicerna Pharmaceuticals, Inc. Announces Dosing Completion in Nedosiran Phyox4 Clinical ..
11.06.Vertex Won't Move VX-864 into Late-Stage Testing After Disappointing Study Results
04.06.DICERNA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-..
03.06.DICERNA PHARMACEUTICALS : to Participate in 42nd Annual Goldman Sachs Global Healthcare Co..
01.06.DICERNA PHARMACEUTICALS : Corporate Overview
28.05.DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational New Drug (IN..
27.05.DICERNA PHARMACEUTICALS : Says Partner Eli Lilly's Investigational New Drug Application fo..
27.05.DICERNA PHARMACEUTICALS : Corporate Overview
27.05.DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational New Drug (IN..
27.05.Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug Application for LY..
24.05.SECTOR UPDATE : Health Care Stocks Still Narrowly Higher in Late Regular-Hours Trade
24.05.DICERNA PHARMACEUTICALS' : DCR-LIV2 Accepted for Advancement Under Boehringer Ingelheim De..
24.05.DICERNA PHARMACEUTICALS : Announces Boehringer Ingelheim's Acceptance of Candidate for Dev..
24.05.Dicerna Announces Boehringer Ingelheim’s Acceptance of Candidate for Development Under ..
12.05.DICERNA PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
12.05.DICERNA PHARMACEUTICALS : Corporate Overview
07.05.DICERNA PHARMACEUTICALS : Earned $25 Million Milestone Payment in Connection With Roche's ..
06.05.DICERNA PHARMACEUTICALS : Q1 Earnings Snapshot
06.05.DICERNA PHARMACEUTICALS : Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Posts Q1 Revenue $..
06.05.DICERNA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
1  2  3  4  5  6  7  8Weiter
Anstehende Termine für DICERNA PHARMACEUTICALS, INC.